
Company valuation, historical trends, and peer comparisons.
According to enGene Holdings Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 93.78M. This represents a change of -76.80% compared to the average of 404.23M of the last 4 quarters.
The mean historical Enterprise Value of enGene Holdings Inc. over the last ten years is 277.35M. The current 93.78M Enterprise Value has changed -66.19% with respect to the historical average. Over the past ten years (40 quarters), ENGN's Enterprise Value was at its highest in in the January 2026 quarter at 637.87M. The Enterprise Value was at its lowest in in the July 2026 quarter at 117.07M.
Average
277.35M
Median
333.70M
Minimum
0
Maximum
399.40M
Discovering the peaks and valleys of enGene Holdings Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual Enterprise Value = 399.40M
Minimum Annual Increase = -38.14%
Minimum Annual Enterprise Value = 0
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 350.21M | 41.75% |
| 2024 | 247.06M | -38.14% |
| 2023 | 399.40M | 14.75% |
| 2022 | 348.06M | 8.99% |
| 2021 | 319.35M | Infinity% |
The current Enterprise Value of enGene Holdings Inc. (ENGN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
332.23M
5-year avg
332.82M
10-year avg
277.35M
enGene Holdings Inc.’s Enterprise Value is less than Amarin Corporation plc (100.53M), less than Altimmune, Inc. (379.24M), less than Korro Bio, Inc. (227.52M), less than DBV Technologies S.A. (178.31M), less than Larimar Therapeutics, Inc. (170.42M), less than Cellectis S.A. (129.33M), less than Annexon, Inc. (486.49M), less than Alto Neuroscience, Inc. (646.66M), less than AC Immune S.A. (148.51M), less than Silence Therapeutics plc (862.11M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 100.53M | $249.43M | |
| 379.24M | $406.54M | |
| 227.52M | $210.21M | |
| 178.31M | $224.74M | |
| 170.42M | $258.15M | |
| 129.33M | $110.96M | |
| 486.49M | $661.10M | |
| 646.66M | $883.34M | |
| 148.51M | $210.16M | |
| 862.11M | $934.05M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like enGene Holdings Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like enGene Holdings Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is enGene Holdings Inc.'s Enterprise Value?
What is the highest Enterprise Value for enGene Holdings Inc. (ENGN)?
What is the 3-year average Enterprise Value for enGene Holdings Inc. (ENGN)?
What is the 5-year average Enterprise Value for enGene Holdings Inc. (ENGN)?
How does the current Enterprise Value for enGene Holdings Inc. (ENGN) compare to its historical average?